2Scott NA, Cipolla GD, Ross CE, et al. Identification of a potential role for the adventifia in vascular lesion formation after balloon overstretch injmy of porcine coronary arteries[J]. Circulation, 1996, 93(12) : 2178 - 2187.
3Okatani Y, Wakatsuki A, Reiter RJ. Melatonin counteracts potentiation by homocysteine of KC1 - induced vasocomtriction in human umbilical artery: relation to calcium influx [ J].Biochem Biophys Res Commun, 2001,280(3) : 940 - 944.
4Hart BA, Prabhu RM, Eneman JD, et al. Oxidant resistance of cadmium - adapted human lung fibroblasts[ J]. Toxicology,1995,98(1-3): 1 - 13.
5Whelchel A, Evans J, Posada J. Inhibition of ERK activation attenuates endothelin - stimulated airway smooth muscle cell proliferation[J]. Am J Respir Cell Mol Biol, 1997, 16(5):589 - 596.
6Eaton DL, Toal BF. Evaluation of the Cd/hemoglobin affnaity assay for the rapid determination of metallothionein in biological tissues[J]. Toxicol Appl Pharmacol, 1982, 66(1):134-142.
7Lee ME, Wang H. Homocysteine and hypomethylafion. A novel link to vascular dlsease[J]. Trends Cardiovasc Med,1999,9(1 - 2) : 49 - 54.
8Chambers C, Obeid OA, Refsum H, et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men [ J]. Lancet, 2000,355(9203) : 523 - 527.
9Jones BG, Rose FA, Tudball N. Lipid peroxidation and homocysteine - induced toxicity[ J]. Atherosclerosis, 1994, 105(2) : 165 - 170.
10Sakurai A, Ham S, Okano N, et al. Regulatory role of metallothionein in NF- кB activation[J]. FEBS Letter, 1999,455(1 - 2):55- 58.
